凯基生物 (835272.OC)

+ 收藏

利润表(凯基生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2024年一季报2023年年报2023年中报2023年一季报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 37,580,504.0116,995,920.4860,205,706.6130,545,216.1010,987,810.98111,929,005.9368,729,131.39
 营业收入(元) 37,580,504.0116,995,920.4860,205,706.6130,545,216.1010,987,810.98111,929,005.9368,729,131.39
二、营业总成本(元) 37,423,814.8318,851,296.0496,368,961.4944,043,960.0119,135,112.94131,111,063.4474,296,367.91
 营业成本(元) 21,966,310.3412,001,254.8651,276,296.2324,588,216.5610,998,836.1787,162,933.8555,465,096.04
 研发费用(元) 3,790,151.542,120,610.209,308,409.214,284,202.81983,754.798,331,975.762,793,235.01
 营业税金及附加(元) 124,796.6286,199.83359,705.19102,904.5651,820.19622,373.01376,348.34
 销售费用(元) 6,796,319.682,667,296.6719,970,456.839,237,820.744,465,364.9919,037,686.719,165,403.23
 管理费用(元) 4,246,061.421,732,150.5614,786,948.505,626,014.042,555,422.1215,707,125.966,477,403.76
 财务费用(元) 500,175.23243,783.92667,145.53204,801.3079,914.68248,968.1518,881.53
  其中:利息费用(元) 498,024.13246,101.94668,505.83203,756.1879,249.85291,151.5358,069.45
  其中:利息收入(元) 6,448.105,167.7218,035.899,112.914,128.9564,940.2751,265.43
三、其他经营收益
 加:公允价值变动收益(元) -----27.00-
 加:投资收益(元) -1,861,167.0946,142.982,045,250.82-525,592.8746,142.9813,749.34-316,308.58
  其中:对联营企业和合营企业的投资收益(元) -1,861,167.09------
 资产减值损失(元) ---430,723.74----
 信用减值损失(元) -450,695.03--2,318,053.93-2,843,855.87--2,388,188.38-323,550.10
 其他收益(元) 984,052.33595,867.122,956,492.63605,617.75528,038.43251,412.04130,430.80
四、营业利润(元) -1,171,120.61-1,213,365.46-33,910,289.10-16,262,574.90-7,573,120.55-21,305,057.51-6,076,664.40
 加:营业外收入(元) 1.480.5119,207.7018,977.07507.74168.108,906.94
 减:营业外支出(元) --1,949,424.51-80,425.90-313,220.66477.31
五、利润总额(元) -1,171,119.13-1,213,364.95-35,840,505.91-16,163,171.93-7,572,612.81-21,618,110.07-6,068,234.77
 减:所得税费用(元) -68,799.16--322,609.94-2,669,374.68--292,062.67-811,026.55
六、净利润(元) -1,102,319.97-1,213,364.95-35,517,895.97-13,493,797.25-7,572,612.81-21,326,047.40-5,257,208.22
(一)按经营持续性分类
  持续经营净利润(元) -1,102,319.97-1,213,364.95-35,517,895.97-13,493,797.25-7,572,612.81-21,326,047.40-
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -1,102,319.97-1,213,364.95-35,517,895.97-13,493,797.25-7,572,612.81-21,326,047.40-5,257,208.22
 扣除非经常性损益后的净利润(元) -1,938,690.83-1,809,232.58-36,735,513.90-14,083,499.65--21,264,433.88-5,374,177.97
七、每股收益
 一、基本每股收益(元) -0.02-0.02-0.59-0.22-0.13-0.36-0.09
 二、稀释每股收益(元) -0.02--0.59-0.22--0.36-0.09
九、综合收益总额(元) -1,102,319.97-1,213,364.95-35,517,895.97-13,493,797.25-7,572,612.81-21,326,047.40-5,257,208.22
 归属于母公司所有者的综合收益总额(元) -1,102,319.97-1,213,364.95-35,517,895.97-13,493,797.25-7,572,612.81-21,326,047.40-5,257,208.22
公告日期 2024-08-052024-04-222024-04-222023-08-282024-04-222023-04-102022-08-31
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院